I recently read that approximately 50 percent of men and 30 percent of women in the US will develop symptomatic heart disease. I wanted to learn more about the scale of the problem and how non-invasive technology can help determine who is at the greatest risk for a cardiovascular episode, Dr. Charles Taylor, co-founder, Chief Scientific Officer, and member of the Board of Directors of HeartFlow joins me on Tech Talks Daily. We discuss how technology is transforming the diagnosis and management of coronary artery disease. We also discuss how the medical community has received HeartFlow and how technology drives a more proactive healthcare approach. About Charles A. Taylor, Ph.D. Dr. Taylor is a co-founder, Chief Technology Officer (CTO), and member of the Board of Directors of HeartFlow. Previously, he was an Associate Professor in the Department of Bioengineering and Surgery at Stanford University with courtesy faculty appointments in the Departments of Mechanical Engineering and Radiology. He is internationally recognized for the development of computer modeling and imaging techniques for cardiovascular disease research, device design, and treatment planning. He received his BS degree in Mechanical Engineering, MS degree in Mechanical Engineering, and MS degree in Mathematics from Rensselaer Polytechnic Institute and a Ph.D. in Mechanical Engineering from Stanford University.